Last updated on January 2019

Safety and Preliminary Efficacy of Sequential Multiple Ascending Doses of Solnatide to Treat Pulmonary Permeability Oedema in Patients With Moderate-to-severe ARDS

Brief description of study

This phase IIb, randomized, placebo-controlled, double-blind, dose escalation study will assess the local and systemic safety of 7 days orally inhaled sequential multiple ascending doses of solnatide in patients with pulmonary permeability oedema and moderate-to-severe ARDS and review potential efficacy endpoints for a future phase III pivotal trial.

Clinical Study Identifier: NCT03567577

Contact Investigators or Research Sites near you

Start Over

Roman Ullrich, Prof.

Department of Anesthesia, General Intensive Care and Pain Control,Medical University of Vienna
Vienna, Austria
  Connect »

Michael Schörghuber, Dr. med.

Univ.-klinik f. Herz-, Thorax-, Gef chirurgische An sthesiologie und lntensivmedizin, Medizinische Universit t Graz
Graz, Austria
  Connect »

Sandra Högl, PD Dr.

Klinik f r Anaesthesiologie, Klinikum der Universit t M nchen, Campus Gro hadern
München, Germany
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.